1.
Mortality in participants and non-participants of a multifactorial prevention study of cardiovascular diseases: a 28 year follow up of the Helsinki Businessmen Study
by Strandberg, T. E
British Heart Journal, 1995-10, Vol.74 (4), p.449-454
2.
Cholesterol malabsorption caused by sitostanol ester feeding and neomycin in pravastatin-treated hypercholesterolaemic patients
by VANHANEN, H
European journal of clinical pharmacology, 1994, Vol.47 (2), p.169-176
3.
The problem-based learning tutorial laboratory - a method for training medical teachers
by Vanhanen, Kaisu Pitkälä, Pauli Puolakkainen, Timo E. Strandberg, Kirsti Lonka, Hannu
Medical teacher, 2001, Vol.23 (1), p.99-101
4.
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
by Forette, Françoise
The Lancet (British edition), 1998, Vol.352 (9137), p.1347-1351
5.
Effect of statins on C-reactive protein in patients with coronary artery disease
by Strandberg, Timo E
The Lancet (British edition), 1999, Vol.353 (9147), p.118-119
6.
Evidence-based medicine - how to teach critical scientific thinking to medical undergraduates
by Pitkala, K
Medical teacher, 2000, Vol.22 (1), p.22-26
7.
SERUM CHOLESTEROL RESPONSE TO DIETARY CHOLESTEROL AND APOPROTEIN E PHENOTYPE
by Miettinen, T.A
The Lancet (British edition), 1988, Vol.332 (8622), p.1261-1261
8.
The decline in cardiovascular disease: there is still room for improvement
by Vanhanen, Hannu
International journal of food sciences and nutrition, 2004, Vol.38 (4), p.197-199
9.
Replacement of Margarine on Bread by Rapeseed and Olive Oils: Effects on Plasma Fatty Acid Composition and Serum Cholesterol
by Seppänen-Laakso, T
Annals of nutrition and metabolism, 1993-01-01, Vol.37 (4), p.161-174
10.
Pravastatin and lovastatin similarly reduce serum cholesterol and its precursor levels in familial hypercholesterolaemia
by VANHANEN, H
European journal of clinical pharmacology, 1992, Vol.42 (2), p.127-130
11.
A Consensus View on the Technique of Ambulatory Blood Pressure Monitoring
by Staessen, Jan A
Hypertension (Dallas, Tex. 1979), 1995-12, Vol.26 (6), p.912-918
12.
Effects of acipimox and cholestyramine on serum lipoproteins, non-cholesterol sterols and cholesterol absorption and elimination
by GYLLING, H
European journal of clinical pharmacology, 1989, Vol.37 (2), p.111-115
13.
Serum cholesterol response to dietary cholesterol and apoprotein E phenotype
by Miettinen, T A
The Lancet (British edition), 1988-11-26, Vol.2 (8622), p.1261-1261
14.
Frequency of lipid-lowering therapy after a coronary event in Helsinki, Finland
by Strandberg, Timo E
The American journal of cardiology, 1999, Vol.84 (1), p.95-95
15.
Ambulatory Monitoring Uncorrected for Placebo Overestimates Long-term Antihypertensive Action
by Staessen, Jan A
Hypertension (Dallas, Tex. 1979), 1996-03, Vol.27 (3), p.414-420
16.
Comparison of effects on sleep of lovastatin and pravastatin in hypercholesterolemia
by Partinen, Markku
The American journal of cardiology, 1994, Vol.73 (12), p.876-880
17.
Ambulatory monitoring uncorrected for placebo overestimates long-term antihypertensive action. Systolic Hypertension in Europe (SYST-EUR) Trial Investigators
by Staessen, J A
Hypertension (Dallas, Tex. 1979), 1996-03, Vol.27 (3 Pt 1), p.414-420
18.
Long-term use of probucol in the multifactorial primary prevention of vascular disease
by Miettinen, Tatu A
The American journal of cardiology, 1986, Vol.57 (16), p.H49-H54
19.
A voxel based morphometry study on mild cognitive impairment
by Pennanen, C
Journal of neurology, neurosurgery and psychiatry, 2005-01, Vol.76 (1), p.11-14
20.
Process for biological oxidation and control of dissolved iron in bioleach liquors
by Nurmi, P
Process biochemistry (1991), 2009, Vol.44 (12), p.1315-1322
